Home › Companies › Boston Scientific Corporation › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Boston Scientific Corporation’s Form 8-K, filed May 5, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of April 30, 2026: 17 items on Boston Scientific Corporation’s Form 8-K, filed May 5, 2026: 10 elected · 5 approved · 2 not approved.
High dissent: 1 shareholder proposal (42.8% support).
Notable dissent: 1 director (14.1% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Boston Scientific Corporation in the interactive database Compare manager voting policies
These tallies are Boston Scientific Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: David C. Habiger | 1,037,805,652 | 169,730,106 | 2,858,635 | -- | 81,271,529 | 86% | Elected | — |
| Elect Director: Edward J. Ludwig | 1,156,469,560 | 50,835,636 | 3,089,197 | -- | 81,271,529 | 96% | Elected | — |
| Elect Director: Michael F. Mahoney | 1,113,612,016 | 93,613,027 | 3,169,350 | -- | 81,271,529 | 92% | Elected | — |
| Elect Director: Jessica L. Mega | 1,196,020,676 | 11,532,045 | 2,841,672 | -- | 81,271,529 | 99.0% | Elected | — |
| Elect Director: Susan E. Morano | 1,171,890,417 | 35,662,932 | 1,841,044 | -- | 81,271,529 | 97% | Elected | — |
| Elect Director: Cheryl Pegus | 1,195,889,562 | 11,653,832 | 2,850,999 | -- | 81,271,529 | 99.0% | Elected | — |
| Elect Director: Cathy R. Smith | 1,117,908,896 | 88,044,911 | 4,440,586 | -- | 81,271,529 | 93% | Elected | — |
| Elect Director: Christophe P. Weber | 1,205,365,637 | 2,260,256 | 2,768,500 | -- | 81,271,529 | 99.8% | Elected | — |
| Elect Director: David S. Wichmann | 1,198,736,185 | 8,393,038 | 3,265,170 | -- | 81,271,529 | 99.3% | Elected | — |
| Elect Director: Ellen M. Zane | 1,150,092,668 | 56,753,553 | 3,548,172 | -- | 81,271,529 | 95% | Elected | — |
| 2. The compensation of the Company's "Named Executive Officers" as disclosed in the Company's proxy statement for the Annual Meeting | 1,096,889,576 | 110,645,813 | 2,859,004 | -- | 81,271,529 | 91% | Approved | — |
| 3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2026 fiscal year | 1,169,955,769 | 116,874,243 | 4,835,910 | -- | 0 | 91% | Approved | — |
| 4. The amendment of the Company's Employee Stock Purchase Plan to increase the number of shares reserved for issuance | 1,205,130,032 | 2,818,667 | 2,445,694 | -- | 81,271,529 | 99.8% | Approved | — |
| 5. The amendment of the Company's Third Restated Certificate of Incorporation to remove supermajority voting provisions | 1,189,271,431 | 17,774,053 | 3,348,909 | -- | 81,271,529 | 99% | Approved | — |
| 6. The amendment of the Company's Third Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law | 1,057,086,923 | 150,458,633 | 2,848,837 | -- | 81,271,529 | 88% | Approved | — |
| 7. The amendment of the Company's Third Restated Certificate of Incorporation and Amended and Restated By-Laws to permit stockholders owning not less than 25% of the Company's common stock to call a special meeting of stockholders | 1,095,371,430 | 20,945,183 | 94,077,780 | -- | 81,271,529 | 98% | Not approved Not approved: the filing states that this item needed more than a majority of the votes cast. | — |
| 8. Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." | 516,140,863 | 689,739,605 | 4,513,925 | -- | 81,271,529 | 43% | Not approved | — |
Source: Boston Scientific Corporation, Form 8-K, filed with the SEC on May 5, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
1,259 asset managers disclosed a vote on at least one Boston Scientific Corporation item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Prior year: 95.3% for (May 1, 2025 meeting) ▼ 9.4 pts
Description as filed by funds: Proposal to elect ten Directors: David C. Habiger
Boston Scientific Corporation’s own tally for this item (“Elect Director: David C. Habiger”): 1,037,805,652 for, 169,730,106 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 210 asset managers below reported 445,056,498 for, 32,670,409 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 155,269,860 | 10,730,048 | 15 | 0 | Mixed |
| Fidelity | 97,156,092 | 20,264 | 0 | 0 | For |
| BlackRock | 47,761,377 | 0 | 0 | 0 | For |
| State Street | 18,264,340 | 0 | 0 | 0 | For |
| Capital Group | 0 | 16,587,637 | 0 | 0 | Against |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 0 | 2,393,727 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,542,413 | 22,548 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 96.7% for (May 1, 2025 meeting) ▼ 0.9 pts
Description as filed by funds: Proposal to elect ten Directors: Edward J. Ludwig
Boston Scientific Corporation’s own tally for this item (“Elect Director: Edward J. Ludwig”): 1,156,469,560 for, 50,835,636 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 210 asset managers below reported 477,276,087 for, 450,820 against, 142,672 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,999,660 | 248 | 17 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,761,377 | 0 | 0 | 0 | For |
| State Street | 18,264,131 | 209 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,564,961 | 0 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Prior year: 92.8% for (May 1, 2025 meeting) ▼ 0.5 pts
Description as filed by funds: Proposal to elect ten Directors: Michael F. Mahoney
Boston Scientific Corporation’s own tally for this item (“Elect Director: Michael F. Mahoney”): 1,113,612,016 for, 93,613,027 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 210 asset managers below reported 477,695,132 for, 31,777 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,999,408 | 502 | 15 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,761,377 | 0 | 0 | 0 | For |
| State Street | 18,264,224 | 116 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,542,413 | 22,548 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Prior year: 99.5% for (May 1, 2025 meeting) ▼ 0.5 pts
Description as filed by funds: Proposal to elect ten Directors: Jessica L. Mega
Boston Scientific Corporation’s own tally for this item (“Elect Director: Jessica L. Mega”): 1,196,020,676 for, 11,532,045 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 210 asset managers below reported 477,594,300 for, 132,605 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,999,877 | 29 | 15 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,761,377 | 0 | 0 | 0 | For |
| State Street | 18,264,340 | 0 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,564,961 | 0 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 99.8% for (May 1, 2025 meeting) ▼ 2.8 pts
Description as filed by funds: Proposal to elect ten Directors: Susan E. Morano
Boston Scientific Corporation’s own tally for this item (“Elect Director: Susan E. Morano”): 1,171,890,417 for, 35,662,932 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 210 asset managers below reported 477,092,478 for, 634,431 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,883,457 | 116,455 | 15 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,752,848 | 8,529 | 0 | 0 | For |
| State Street | 18,264,340 | 0 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,564,961 | 0 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Prior year: 99.8% for (May 1, 2025 meeting) ▼ 0.8 pts
Description as filed by funds: Proposal to elect ten Directors: Cheryl Pegus
Boston Scientific Corporation’s own tally for this item (“Elect Director: Cheryl Pegus”): 1,195,889,562 for, 11,653,832 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 210 asset managers below reported 477,594,300 for, 132,606 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,999,877 | 30 | 15 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,761,377 | 0 | 0 | 0 | For |
| State Street | 18,264,340 | 0 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,564,961 | 0 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Proposal to elect ten Directors: Cathy R. Smith
Boston Scientific Corporation’s own tally for this item (“Elect Director: Cathy R. Smith”): 1,117,908,896 for, 88,044,911 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 210 asset managers below reported 459,103,552 for, 18,623,346 against, 142,680 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,883,103 | 116,798 | 25 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,745,017 | 16,360 | 0 | 0 | For |
| State Street | 18,264,340 | 0 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 7,193 | 8,681,824 | 0 | 0 | Against |
| Parnassus | 0 | 7,000,646 | 0 | 0 | Against |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,542,413 | 22,548 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Proposal to elect ten Directors: Christophe P. Weber
Boston Scientific Corporation’s own tally for this item (“Elect Director: Christophe P. Weber”): 1,205,365,637 for, 2,260,256 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 210 asset managers below reported 477,701,900 for, 25,009 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,999,901 | 9 | 15 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,761,377 | 0 | 0 | 0 | For |
| State Street | 18,264,340 | 0 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,564,961 | 0 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Prior year: 99.1% for (May 1, 2025 meeting) ▲ 0.2 pts
Description as filed by funds: Proposal to elect ten Directors: David S. Wichmann
Boston Scientific Corporation’s own tally for this item (“Elect Director: David S. Wichmann”): 1,198,736,185 for, 8,393,038 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 210 asset managers below reported 477,636,681 for, 90,226 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,999,870 | 38 | 15 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,761,377 | 0 | 0 | 0 | For |
| State Street | 18,264,340 | 0 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,564,961 | 0 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Prior year: 97.0% for (May 1, 2025 meeting) ▼ 1.7 pts
Description as filed by funds: Proposal to elect ten Directors: Ellen M. Zane
Boston Scientific Corporation’s own tally for this item (“Elect Director: Ellen M. Zane”): 1,150,092,668 for, 56,753,553 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 210 asset managers below reported 477,278,422 for, 448,480 against, 142,673 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,999,636 | 267 | 18 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,761,377 | 0 | 0 | 0 | For |
| State Street | 18,264,340 | 0 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,564,961 | 0 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
88% Approved · of votes cast
Description as filed by funds: To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.
Boston Scientific Corporation’s own tally for this item (“6. The amendment of the Company's Third Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law”): 1,057,086,923 for, 150,458,633 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(6) The stockholders approved the amendment of the Company's Third Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 210 asset managers below reported 455,750,059 for, 21,951,848 against, 167,670 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,882,802 | 117,107 | 15 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,720,154 | 41,223 | 0 | 0 | For |
| State Street | 18,262,601 | 1,739 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 8,850,564 | 0 | 0 | Against |
| Charles Schwab | 8,686,495 | 2,522 | 0 | 0 | For |
| Parnassus | 0 | 7,000,646 | 0 | 0 | Against |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,491,857 | 196,423 | 0 | 0 | Mixed |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 0 | 1,605,985 | 0 | 0 | Against |
| Equitable | 1,564,961 | 0 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99% Approved · of votes cast
Description as filed by funds: To amend our Certificate of Incorporation to remove supermajority voting provisions.
Boston Scientific Corporation’s own tally for this item (“5. The amendment of the Company's Third Restated Certificate of Incorporation to remove supermajority voting provisions”): 1,189,271,431 for, 17,774,053 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(5) The stockholders approved the amendment of the Company's Third Restated Certificate of Incorporation to remove supermajority voting provisions.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 204 asset managers below reported 476,479,462 for, 50,103 against, 18 abstained, 1,125 not voted, 24,011 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,999,803 | 103 | 18 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,761,377 | 0 | 0 | 0 | For |
| State Street | 18,264,340 | 0 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,564,961 | 0 | 0 | 0 | For |
Showing the 25 largest of 204 asset managers. All 204 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
98% Not approved · of votes cast
Description as filed by funds: To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders.
Boston Scientific Corporation’s own tally for this item (“7. The amendment of the Company's Third Restated Certificate of Incorporation and Amended and Restated By-Laws to permit stockholders owning not less than 25% of the Company's common stock to call a special meeting of st”): 1,095,371,430 for, 20,945,183 against — failed, per its Form 8-K filed May 5, 2026 (Item 5.07). This item required more than a simple majority of votes cast — see the filing.
Reported outcome: Not approved, in the filing’s own words: “(7) The stockholders did not approve the amendment of the Company's Third Restated Certificate of Incorporation and Amended and Restated By-Laws to permit stockholders owning not less than 25% of the Company's common stock to call a special meeting of stockholders.”
Not approved: the filing states that this item needed more than a majority of the votes cast.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 204 asset managers below reported 442,277,448 for, 328,263 against, 33,923,684 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 136,296,214 | 203,763 | 29,499,947 | 0 | Mixed |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,719,106 | 25,911 | 16,360 | 0 | For |
| State Street | 18,234,526 | 29,814 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,686,495 | 0 | 2,522 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 0 | 1,606,600 | 0 | Abstain |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,564,961 | 0 | 0 | 0 | For |
Showing the 25 largest of 204 asset managers. All 204 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Description as filed by funds: To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance.
Boston Scientific Corporation’s own tally for this item (“4. The amendment of the Company's Employee Stock Purchase Plan to increase the number of shares reserved for issuance”): 1,205,130,032 for, 2,818,667 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(4) The stockholders approved the amendment of the Company's Employee Stock Purchase Plan to increase the number of shares reserved for issuance.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 226 asset managers below reported 480,572,132 for, 151,281 against, 13 abstained, 1,125 not voted, 24,198 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,999,898 | 15 | 13 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,761,377 | 0 | 0 | 0 | For |
| State Street | 18,264,340 | 0 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| Navera Investment Management Ltd. | 1,615,514 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
Showing the 25 largest of 226 asset managers. All 226 are in the interactive database (link above).
Combines 29 wordings of this item as funds reported it.
91% Approved · of votes cast
Prior year: 91.9% for (May 1, 2025 meeting) ▼ 1.0 pts
Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of our named executive officers.
Boston Scientific Corporation’s own tally for this item (“2. The compensation of the Company's "Named Executive Officers" as disclosed in the Company's proxy statement for the Annual Meeting”): 1,096,889,576 for, 110,645,813 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(2) The stockholders approved, on an advisory basis, the compensation of the Company's "Named Executive Officers" as disclosed in the Company's proxy statement for the Annual Meeting.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Boston Scientific Corporation’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Say on Pay” (3 managers, 98,123 for, 2,560 against).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,999,319 | 589 | 15 | 0 | For |
| Fidelity | 97,176,356 | 0 | 0 | 0 | For |
| BlackRock | 47,761,377 | 0 | 0 | 0 | For |
| State Street | 18,264,131 | 209 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,029,758 | 15,000 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,542,413 | 22,548 | 0 | 0 | For |
Fund voting reports, all 198 managers: 476,203,300 for, 565,671 against, 142,670 abstained, 1,126 not voted, 24,011 unknown. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 80,564,580 | 0 | 0 | 0 | For |
| BlackRock | 67,411,006 | 5,871 | 0 | 0 | For |
| State Street | 42,639,760 | 463,415 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 33,079,391 | 0 | 0 | 0 | For |
| Janus Henderson | 32,546,057 | 49,734 | 0 | 0 | For |
| PRIMECAP MANAGEMENT CO/CA/ | 31,580,364 | 0 | 0 | 0 | For |
| Invesco | 21,680,726 | 0 | 0 | 0 | For |
| UBS | 16,478,764 | 547,813 | 0 | 0 | For |
| Vanguard | 15,025,630 | 0 | 0 | 0 | For |
| Capital Group | 14,948,991 | 0 | 0 | 0 | For |
| Amundi | 0 | 13,822,851 | 0 | 0 | Against |
| Putnam | 13,790,992 | 0 | 0 | 0 | For |
| Wellington | 12,766,197 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 12,082,671 | 0 | 0 | 0 | For |
| Union Investment Management GmbH | 0 | 11,973,403 | 0 | 0 | Against |
| DE Shaw | 11,514,401 | 0 | 0 | 0 | For |
| Nuveen | 11,475,067 | 694 | 0 | 0 | For |
| Goldman Sachs | 10,688,062 | 0 | 0 | 0 | For |
| Northern Trust | 10,524,833 | 82,943 | 0 | 0 | For |
| T. Rowe Price | 9,136,442 | 35,438 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 8,562,041 | 533,010 | 0 | 0 | Mixed |
| Charles Schwab | 8,900,835 | 0 | 0 | 0 | For |
| Parnassus | 7,805,249 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 7,215,487 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 7,063,996 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1,097 managers: 735,767,804 for, 83,717,534 against, 1,151,156 abstained, 411,068 not voted, 187 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
91% Approved · of votes cast
Prior year: 91.4% for (May 1, 2025 meeting) ▼ 0.5 pts
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year.
Boston Scientific Corporation’s own tally for this item (“3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2026 fiscal year”): 1,169,955,769 for, 116,874,243 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(3) The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2026 fiscal year.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 211 asset managers below reported 475,132,222 for, 2,595,580 against, 142,679 abstained, 1,125 not voted, 24,011 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 165,882,980 | 116,922 | 24 | 0 | For |
| Fidelity | 97,056,397 | 119,959 | 0 | 0 | For |
| BlackRock | 47,752,848 | 8,529 | 0 | 0 | For |
| State Street | 18,264,131 | 209 | 0 | 0 | For |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 11,025,511 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 10,623,370 | 0 | 0 | 0 | For |
| Putnam | 9,521,641 | 0 | 0 | 0 | For |
| Invesco | 8,985,711 | 0 | 0 | 0 | For |
| JPMorgan | 8,850,564 | 0 | 0 | 0 | For |
| Charles Schwab | 8,689,017 | 0 | 0 | 0 | For |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 5,192,491 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 3,412,217 | 0 | 0 | 0 | For |
| Dimensional | 3,064,670 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,044,758 | 0 | 0 | 0 | For |
| Jackson National | 2,688,280 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 2,413,436 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,307,126 | 0 | 0 | 0 | For |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,606,600 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,605,985 | 0 | 0 | 0 | For |
| Equitable | 1,542,413 | 22,548 | 0 | 0 | For |
Showing the 25 largest of 211 asset managers. All 211 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
43% Not approved · of votes cast
Boston Scientific Corporation’s own tally for this item (“8. The stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."”): 516,140,863 for, 689,739,605 against — failed, per its Form 8-K filed May 5, 2026 (Item 5.07).
Reported outcome: Not approved, in the filing’s own words: “(8) The stockholders did not approve the stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."”
Support: 43% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 208 asset managers below reported 79,985,967 for, 397,025,465 against, 142,680 abstained, 1,125 not voted, 25,007 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,626,825 | 154,373,075 | 25 | 0 | Mixed |
| Fidelity | 1,264,983 | 95,911,373 | 0 | 0 | Against |
| BlackRock | 79,115 | 47,682,262 | 0 | 0 | Against |
| State Street | 35,887 | 18,228,453 | 0 | 0 | Against |
| Capital Group | 16,587,637 | 0 | 0 | 0 | For |
| TIAA | 0 | 11,025,511 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 7,545,466 | 3,077,904 | 0 | 0 | Mixed |
| Putnam | 0 | 9,521,641 | 0 | 0 | Against |
| Invesco | 4,742,850 | 4,242,861 | 0 | 0 | Mixed |
| JPMorgan | 0 | 8,850,564 | 0 | 0 | Against |
| Charles Schwab | 2,522 | 8,686,495 | 0 | 0 | Against |
| Parnassus | 7,000,646 | 0 | 0 | 0 | For |
| MFS | 0 | 5,192,491 | 0 | 0 | Against |
| ADVISORS' INNER CIRCLE FUND | 74,618 | 3,337,599 | 0 | 0 | Against |
| Dimensional | 0 | 3,064,670 | 0 | 0 | Against |
| T. Rowe Price | 0 | 3,044,758 | 0 | 0 | Against |
| Jackson National | 1,485,671 | 1,202,609 | 0 | 0 | Mixed |
| Columbia Threadneedle | 2,629,510 | 0 | 0 | 0 | For |
| MASSACHUSETTS INVESTORS GROWTH STOCK FUND | 0 | 2,413,436 | 0 | 0 | Against |
| NEW ECONOMY FUND | 2,393,727 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 2,307,126 | 0 | 0 | Against |
| Eaton Vance | 1,680,678 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 1,606,600 | 0 | 0 | Against |
| Neuberger Berman | 0 | 1,605,985 | 0 | 0 | Against |
| Equitable | 1,184,088 | 380,873 | 0 | 0 | Mixed |
Showing the 25 largest of 208 asset managers. All 208 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of May 1, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 1,486,355,179 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 11.17% |
| 2 | Fidelity | 6.54% |
| 3 | BlackRock | 3.21% |
| 4 | State Street | 1.23% |
| 5 | Capital Group | 1.12% |
| 6 | TIAA | 0.74% |
| 7 | JANUS INVESTMENT FUND | 0.71% |
| 8 | Putnam | 0.64% |
| 9 | Invesco | 0.60% |
| 10 | JPMorgan | 0.60% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 5.42% |
| 2 | BlackRock | 4.54% |
| 3 | State Street | 2.90% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.23% |
| 5 | Janus Henderson | 2.19% |
| 6 | PRIMECAP MANAGEMENT CO/CA/ | 2.12% |
| 7 | Invesco | 1.46% |
| 8 | UBS | 1.15% |
| 9 | Vanguard | 1.01% |
| 10 | Capital Group | 1.01% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 131,822,037 | 8.87% | Form 13F, quarter ended March 31, 2026 |
| FMR (Fidelity) | 74,226,395 | 4.99% | Form 13F, quarter ended March 31, 2026 |
| State Street | 67,986,847 | 4.57% | Form 13F, quarter ended March 31, 2026 |
| JPMorgan Chase | 33,350,157 | 2.24% | Form 13F, quarter ended March 31, 2026 |
| D.E. Shaw | 24,432,352 | 1.64% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 22,960,556 | 1.54% | Form 13F, quarter ended March 31, 2026 |
| Goldman Sachs | 19,366,624 | 1.30% | Form 13F, quarter ended March 31, 2026 |
| Wellington Management | 18,833,406 | 1.27% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 1,486,355,179 shares outstanding, as reported by Boston Scientific Corporation on its Form 10-Q dated April 29, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Boston Scientific Corporation's shareholder meeting held April 30, 2026, in the 2025-2026 proxy season, 1,259 asset managers reported votes on at least one of its 17 ballot items in their SEC Form N-PX filings, covering 21,280 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of our named executive officers. — Boston Scientific Corporation's filing reports the proposal as approved, with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Boston Scientific Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 5, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Boston Scientific Corporation’s 10-Q dated April 29, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Boston Scientific Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Boston Scientific (BSX) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/boston-scientific-corp/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.